0001567619-18-002984.txt : 20180920 0001567619-18-002984.hdr.sgml : 20180920 20180920193348 ACCESSION NUMBER: 0001567619-18-002984 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20180918 FILED AS OF DATE: 20180920 DATE AS OF CHANGE: 20180920 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Feener Edward P. CENTRAL INDEX KEY: 0001691090 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-36830 FILM NUMBER: 181080375 MAIL ADDRESS: STREET 1: ONE KENDALL SQUARE, BUILDING 200 STREET 2: SUITE 2203 CITY: CAMBRIDGE STATE: MA ZIP: 02139 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: KalVista Pharmaceuticals, Inc. CENTRAL INDEX KEY: 0001348911 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 200915291 STATE OF INCORPORATION: DE FISCAL YEAR END: 0430 BUSINESS ADDRESS: STREET 1: ONE KENDALL SQUARE STREET 2: BUILDING 200, STE. 2203 CITY: CAMBRIDGE STATE: MA ZIP: 02139 BUSINESS PHONE: (857) 999-0075 MAIL ADDRESS: STREET 1: ONE KENDALL SQUARE STREET 2: BUILDING 200, STE. 2203 CITY: CAMBRIDGE STATE: MA ZIP: 02139 FORMER COMPANY: FORMER CONFORMED NAME: Carbylan Therapeutics, Inc. DATE OF NAME CHANGE: 20140916 FORMER COMPANY: FORMER CONFORMED NAME: Carbylan Biosurgery, Inc DATE OF NAME CHANGE: 20130102 FORMER COMPANY: FORMER CONFORMED NAME: Carbylan Biosurgery Inc DATE OF NAME CHANGE: 20060105 4 1 doc1.xml FORM 4 X0306 4 2018-09-18 0 0001348911 KalVista Pharmaceuticals, Inc. KALV 0001691090 Feener Edward P. C/O KALVISTA PHARMACEUTICALS, INC. 55 CAMBRIDGE PARKWAY, SUITE 901E CAMBRIDGE MA 02142 0 1 0 0 Chief Scientific Officer Common Stock 2018-09-18 4 A 0 12500 0 A 110534 D Common Stock 2018-09-18 4 F 0 2500 17.05 D 108034 D Employee Stock Option (Right to Buy) 16.08 2018-09-18 4 A 0 52600 0 A 2028-09-17 Common Stock 52600 52600 D Represents the number of shares vested upon the achievement of certain performance criteria pursuant to a performance based restricted stock units ("PSUs") granted by the Issuer's Compensation Committee in June 2018. No sale or disposition of these shares is contemplated until after the expiration of the applicable lock-up period. Represents the number of shares of common stock that have been withheld by the issuer to satisfy its income tax withholding and remittance obligations in connection with the net settlement of the PSUs and does not represent a sale by the reporting person. The option vests over a 4 year period: 1/48th on October 18, 2018, after which 1/48th of the total shares vest monthly, subject to continued service through each vesting date. /s/Benjamin Palleiko, Attorney-in-Fact 2018-09-20